Liquidity Events

Bain Capital sells shares worth Rs.289-Cr in Emcure Pharma

MoneyControl  

BC Investments IV, an affiliate of PE firm Bain Capital, has sold a 0.9% stake in Pune-based Emcure Pharmaceuticals via open market transactions on April 29. The sale of 18 lakh shares at a price of INR 1,608.2 per share, fetched INR 289.47 crore. Norway-based Norges Bank was the buyer,As of March 2026, BC Investments IV had held a 3.87% stake in the pharmaceutical firm.Emcure, set up in 1981, focuses on generics, injectables, and biotherapeutics, with a strong presence in gynecology, cardiovascular, HIV, oncology, and blood-related therapeutic areas.

Bain Capital had invested USD 107 M in Emcure as part of its series B round in Apr 2014.

Want to receive such news items in your inbox? Click Here to sign up for a trial.

2021 © TSJ Media Pvt Ltd. All rights reserved.